Skip to main content
. Author manuscript; available in PMC: 2012 May 9.
Published in final edited form as: J Dev Behav Pediatr. 2012 May;33(4):309–318. doi: 10.1097/DBP.0b013e31824501c8

Table 5.

Psychopharmacologic Medication Treatment of Attention-Deficit Hyperactivity Disorder by Sex Chromosome Aneuploidy Group

47, XXY 47, XYY 47, XXX 48, XXYY
N 30 25 10 36
Stimulants
 Positive response 73% (19/26) 79% (15/19) 75% (6/8) 84% (26/31)
 Negative response 27% (7/26) 21% (4/19) 25% (2/8) 16% (5/31)
Nonstimulants (guanfacine, clonidine, and atomoxetine)
 Positive response 3/4 5/6 2/2 5/5
 Negative response 1/4 1/6 0/2 0/5